It was a busy week for the biotech sector. While the fourth-quarter earnings season is nearing the end, other pipeline and ...

A groundbreaking injectable designed to curb the global spread of HIV is now at risk of being delayed due to Donald Trump's ...

The latest announcement follows the recent US Food and Drug Administration (FDA) acceptance of the company’s new drug ...

Foster City, California Tuesday, February 25, 2025, 16:00 Hrs [IST] ...

The EMA is set to perform accelerated reviews of Gilead Sciences’ applications for its twice-yearly injectable for HIV ...

Gilead (GILD) announced that the European Medicines Agency has validated for parallel accelerated review the company’s marketing authorization ...

Schrödinger today announced that management will participate in the following conferences in March: TD Cowen 45th Annual Health Care Conference: Fireside chat on Tuesday, March 4, 2025 at 10:30 a.m. E ...

Petra Cares is proud to announce the 2nd Annual Petra Cares Gala, a fundraising event dedicated to empowering young adults transitioning out of foster care and homeless, at-risk youth. The gala will ...

US antivirals giant Gilead Sciences recently announced that the US Food and Drug Administration (FDA) has accepted its New ...

We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...

The American quant hedge fund Renaissance Technologies is known for using statistical and mathematical tools to drive its ...

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.